Karl Willis
PFD Report
All Responded
Ref: 2018-0256
All 1 response received
· Deadline: 19 Oct 2018
Sent To
Response Status
Responses
1 of 1
56-Day Deadline
19 Oct 2018
All responses received
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Coroner's Concerns
(1) Amitriptyline is well recognised to have toxic effects when taken in excessive amounts or in conjunction with other medication
(2) Permitting the patient to "self certify" without any checks he can appropriately access this medication can allow the patient to give inaccurate answers and therefore the questionnaire is open to deliberate abuse by those most vulnerable who have addiction problems (3) Permitting the patient the of not having the GP informed removes an otherwise effective safeguard. The GP had worked with extreme care and supported the patient over many months to try and reduce his excessive reliance on polypharmacy.
(2) Permitting the patient to "self certify" without any checks he can appropriately access this medication can allow the patient to give inaccurate answers and therefore the questionnaire is open to deliberate abuse by those most vulnerable who have addiction problems (3) Permitting the patient the of not having the GP informed removes an otherwise effective safeguard. The GP had worked with extreme care and supported the patient over many months to try and reduce his excessive reliance on polypharmacy.
Responses
Response received
View full response
Dear Ms Brown Re: Regulation 28 Report to Prevent Future Deaths Karl James Willis, date of death 06/12/2017 Thank you for your Regulation 28 Report (Report) dated 24 August 2018 concerning the death of Karl Willis on 06/12/2017 . Firstly, would like to express my deep condolences to Karls family: Your Report concludes Karl Willis' death was a result of aspiration pneumonitis secondary to amitriptyline and morphine toxicity. Following the inquest you raised concerns to NHS England regarding the toxic effects of amitriptyline when taken in excessive amounts or in conjunction with other medications_ (ii) Permitting a vulnerable patient to 'self-certify' information on questionnaire to enable them to obtain access to such medication without checks made on the accuracy of the patients answers, and (ii) permitting the option for patients to refuse information to be passed to their GP . It may be helpful if | first explain that NHS England is formally known as the NHS Commissioning Board Board) in legislation (Section 9 Health & Social Care Act 2012 amending Sections 1G & 1H of the NHS Act 2006). The Board's functions and duties are set out in that legislation and include a duty in respect of commissioning arrangements for NHS services. These include commissioning primary care services (including general practice and pharmacy) , managing the NHS performer's lists and maintaining the pharmaceutical list. We have responsibility for ensuring that GPs work within the terms of their contract and pharmacies adhere to their Terms of Service which are outlined in the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations
2013). The Board can take action such as issuing breach notices and requiring action or withholding payments in certain circumstances_ High quality care for all, now and for future generations being
recognise your concerns around the availability of some prescription only medication through the internet; however, when this arises outside the NHS (on private basis in England or abroad) , the Board has limited powers to influence_ In relation to your specific points, amitriptyline is medication which has well known side effects including sedation and in overdose; it can cardio-toxic effects. As an antidepressant; it is less commonly used because of these side effects, but its use is still widespread in clinical practice as a medication that in comparatively low doses is effective in managing pain and anxiety symptoms It is a licensed medication that by law requires a medical prescription before it can be obtained_ It is not a licensed as a controlled under the misuse of drugs legislation. In the case of Karl, the prescription was obtained on a private basis through the internet. The 'consultation' was in the form of an online questionnaire which would have informed the prescribing clinician about relevant past medical history, but as you have indicated, it is dependent on how accurately patient submits their response The use of a questionnaire for patients to 'self-certify' their medical history carries risks that the treating doctor would not be aware Of the full extent of -cpatients past medical history: It is Why there is much Work being done in the NHS to connect NHS services to the patients summary care record sO clinicians can access a summary of the patient's main conditions, To be eligible to provide NHS care; all GPs working in England have to be included on the NHS England 'Performer list' _ The Performer List regulations give the Board responsibility for assuring the quality of GPs providing NHS services in England, The Board has no powers to take action against a clinician who only practices privately; although such doctors do need to maintain their registration with the General Medical Council (GMC) In choosing to access private health care; a patient is stepping outside the NHS, as a result; the Board has no jurisdiction over private consultations and none of the Board's powers relating to community pharmacy, prescriptions or regulation would apply: It remains a patients right to choose to seek private treatment even where this would be detrimental to their health. There is a wider question on whether an online prescriber should be able to prescribe alllcertain medications but this is not in the Board's control, You finally highlight the concern that Karl was given an option to refuse to the details of his consultation with the private on-line provider to be shared with his own GP_ We have checked the website for the provider which has been involved in this case and note that it is recommended that information is shared with patient's own GP_ As you will appreciate whilst most often in patient's best interest for information to be shared, the bar at which it is appropriate for confidentiality to be breached is set high and in the tragic circumstance of Karl Willis, there would have been no legal justification to have breached his confidentiality and informed his GP or anyone else involved in his care_ High quality care for all, now and for future generations have drug have
Thank you for bringing this important patient safety issues to my attention and we hope our response has addressed your concerns: Please do not hesitate to contact me should you need any further information_
2013). The Board can take action such as issuing breach notices and requiring action or withholding payments in certain circumstances_ High quality care for all, now and for future generations being
recognise your concerns around the availability of some prescription only medication through the internet; however, when this arises outside the NHS (on private basis in England or abroad) , the Board has limited powers to influence_ In relation to your specific points, amitriptyline is medication which has well known side effects including sedation and in overdose; it can cardio-toxic effects. As an antidepressant; it is less commonly used because of these side effects, but its use is still widespread in clinical practice as a medication that in comparatively low doses is effective in managing pain and anxiety symptoms It is a licensed medication that by law requires a medical prescription before it can be obtained_ It is not a licensed as a controlled under the misuse of drugs legislation. In the case of Karl, the prescription was obtained on a private basis through the internet. The 'consultation' was in the form of an online questionnaire which would have informed the prescribing clinician about relevant past medical history, but as you have indicated, it is dependent on how accurately patient submits their response The use of a questionnaire for patients to 'self-certify' their medical history carries risks that the treating doctor would not be aware Of the full extent of -cpatients past medical history: It is Why there is much Work being done in the NHS to connect NHS services to the patients summary care record sO clinicians can access a summary of the patient's main conditions, To be eligible to provide NHS care; all GPs working in England have to be included on the NHS England 'Performer list' _ The Performer List regulations give the Board responsibility for assuring the quality of GPs providing NHS services in England, The Board has no powers to take action against a clinician who only practices privately; although such doctors do need to maintain their registration with the General Medical Council (GMC) In choosing to access private health care; a patient is stepping outside the NHS, as a result; the Board has no jurisdiction over private consultations and none of the Board's powers relating to community pharmacy, prescriptions or regulation would apply: It remains a patients right to choose to seek private treatment even where this would be detrimental to their health. There is a wider question on whether an online prescriber should be able to prescribe alllcertain medications but this is not in the Board's control, You finally highlight the concern that Karl was given an option to refuse to the details of his consultation with the private on-line provider to be shared with his own GP_ We have checked the website for the provider which has been involved in this case and note that it is recommended that information is shared with patient's own GP_ As you will appreciate whilst most often in patient's best interest for information to be shared, the bar at which it is appropriate for confidentiality to be breached is set high and in the tragic circumstance of Karl Willis, there would have been no legal justification to have breached his confidentiality and informed his GP or anyone else involved in his care_ High quality care for all, now and for future generations have drug have
Thank you for bringing this important patient safety issues to my attention and we hope our response has addressed your concerns: Please do not hesitate to contact me should you need any further information_
Action Should Be Taken
In my opinion action should be taken to prevent future deaths and believe you have the power to take such action;
Report Sections
Investigation and Inquest
On 14h December 2017 commenced an investigation into the death of Karl James Willis, DOB 19 May 1986_ The investigation concluded at the end of the inquest on 17 August 2018. The conclusion of the inquest was Medical cause of death I1a Aspiration Pneumonitis 1b Amitriptyline and morphine toxicity Conclusion Misadventure
Circumstances of the Death
Karl had been taking substantial amounts of prescribed medication and was under regular review and twice weekly medication collection with an intention to prevent excessive intakeloverdose and to gradually reduce his dependency: A short time before his death; the GP had removed amitriptyline from his prescribed medications and replaced this with another drug, explaining the two should not be taken together: Karl completed and online questionnaire with UK meds and was untruthful in most aspects of the information he disclosed, in order to secure a further online prescription of amitriptyline. He also refused permission for his GP to be advised of this prescription request: Karl was found deceased at home and the toxicology confirmed the concentration of amitriptyline in the blood specimen is well above that seen after therapeutic dosage and within the reported fatal range_ The concentration of morphine is sufficient to have significantly increased toxicity due to the amitriptyline
Similar PFD Reports
Reports sharing organisations, categories, or themes with this PFD
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.